GB201820316D0 - Bicyclic peptide ligands specific for IL-17 - Google Patents

Bicyclic peptide ligands specific for IL-17

Info

Publication number
GB201820316D0
GB201820316D0 GBGB1820316.6A GB201820316A GB201820316D0 GB 201820316 D0 GB201820316 D0 GB 201820316D0 GB 201820316 A GB201820316 A GB 201820316A GB 201820316 D0 GB201820316 D0 GB 201820316D0
Authority
GB
United Kingdom
Prior art keywords
peptide ligands
ligands specific
bicyclic peptide
bicyclic
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1820316.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BicycleRD Ltd
Original Assignee
BicycleRD Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BicycleRD Ltd filed Critical BicycleRD Ltd
Priority to GBGB1820316.6A priority Critical patent/GB201820316D0/en
Publication of GB201820316D0 publication Critical patent/GB201820316D0/en
Priority to US17/309,627 priority patent/US20220024983A1/en
Priority to JP2021534203A priority patent/JP2022515720A/ja
Priority to PCT/GB2019/053534 priority patent/WO2020120978A1/en
Priority to EP19824377.6A priority patent/EP3894007A1/en
Priority to CN201980081501.8A priority patent/CN113474046A/zh
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
GBGB1820316.6A 2018-12-13 2018-12-13 Bicyclic peptide ligands specific for IL-17 Ceased GB201820316D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1820316.6A GB201820316D0 (en) 2018-12-13 2018-12-13 Bicyclic peptide ligands specific for IL-17
US17/309,627 US20220024983A1 (en) 2018-12-13 2019-12-13 Bicyclic peptide ligands specific for il-17
JP2021534203A JP2022515720A (ja) 2018-12-13 2019-12-13 Il-17に特異的な二環式ペプチドリガンド
PCT/GB2019/053534 WO2020120978A1 (en) 2018-12-13 2019-12-13 Bicyclic peptide ligands specific for il-17
EP19824377.6A EP3894007A1 (en) 2018-12-13 2019-12-13 Bicyclic peptide ligands specific for il-17
CN201980081501.8A CN113474046A (zh) 2018-12-13 2019-12-13 Il-17特异性的双环肽配体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1820316.6A GB201820316D0 (en) 2018-12-13 2018-12-13 Bicyclic peptide ligands specific for IL-17

Publications (1)

Publication Number Publication Date
GB201820316D0 true GB201820316D0 (en) 2019-01-30

Family

ID=65146974

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1820316.6A Ceased GB201820316D0 (en) 2018-12-13 2018-12-13 Bicyclic peptide ligands specific for IL-17

Country Status (6)

Country Link
US (1) US20220024983A1 (cg-RX-API-DMAC7.html)
EP (1) EP3894007A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022515720A (cg-RX-API-DMAC7.html)
CN (1) CN113474046A (cg-RX-API-DMAC7.html)
GB (1) GB201820316D0 (cg-RX-API-DMAC7.html)
WO (1) WO2020120978A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021006421A (es) 2018-12-19 2021-08-16 Leo Pharma As Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17).
GB201918559D0 (en) * 2019-12-16 2020-01-29 Bicycle Tx Ltd Bicyclic peptide ligands specific for IL-17
GB201918558D0 (en) * 2019-12-16 2020-01-29 Bicycle Tx Ltd Bicyclic peptide ligands specific for IL-17
EP4077349A1 (en) * 2019-12-16 2022-10-26 BicycleTX Limited Bicyclic peptide ligands specific for il-17
GB201918557D0 (en) * 2019-12-16 2020-01-29 Bicycle Tx Ltd Bicyclic peptide ligands specific for IL-17
JP7664947B2 (ja) 2020-04-30 2025-04-18 ヤンセン ファーマシューティカ エヌ.ベー. Il-17の調節因子としてのイミダゾリダジン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
ES2428869T3 (es) 2005-01-24 2013-11-12 Pepscan Systems B.V. Compuestos de unión, compuestos inmunógenos y peptidomiméticos
PL1963368T6 (pl) 2005-12-13 2021-02-08 Eli Lilly And Company Przeciwciała anty-IL-17
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
US20110223169A1 (en) 2008-11-26 2011-09-15 Stern Michael E Il-17 antibody inhibitor for treating dry eye
WO2011141823A2 (en) 2010-05-14 2011-11-17 Orega Biotech Methods of treating and/or preventing cell proliferation disorders with il-17 antagonists
WO2011163452A2 (en) 2010-06-24 2011-12-29 Eleven Biotherapeutics, Inc. Treating surface of the eye disorders
NZ731185A (en) * 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
EP3181146A1 (en) * 2015-12-16 2017-06-21 Ruprecht-Karls-Universität Heidelberg Cyclic ntcp-targeting peptides and their uses as entry inhibitors
GB201600911D0 (en) * 2016-01-18 2016-03-02 Bicycle Therapeutics Ltd Stabilized peptide derivatives
GB201810327D0 (en) * 2018-06-22 2018-08-08 Bicycletx Ltd Peptide ligands for binding to IL-17

Also Published As

Publication number Publication date
EP3894007A1 (en) 2021-10-20
CN113474046A (zh) 2021-10-01
JP2022515720A (ja) 2022-02-22
US20220024983A1 (en) 2022-01-27
WO2020120978A1 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
ZA202100442B (en) Bicyclic peptide ligands specific for nectin-4
IL275440A (en) EPHA2-specific bicyclic peptide ligands
IL283873B1 (en) Bicyclic peptide ligands specific for MT1-MMP
GB201721265D0 (en) Bicyclic peptide ligands specific for EphA2
GB201820295D0 (en) Bicyclic peptide ligands specific for MT1-MMP
GB201820320D0 (en) Bicyclic peptide ligands specific for FAPalpha
GB201918557D0 (en) Bicyclic peptide ligands specific for IL-17
GB201918559D0 (en) Bicyclic peptide ligands specific for IL-17
GB201918558D0 (en) Bicyclic peptide ligands specific for IL-17
GB201720932D0 (en) Bicyclic peptide ligands specific for IL-17
GB201818499D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201815684D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201918495D0 (en) Bicyclic peptide ligands specific for il-46
GB201820321D0 (en) Bicyclic peptide ligands specific for MMP9
GB201820318D0 (en) Bicyclic peptide ligands specific for cathepsin G
GB201904632D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201820322D0 (en) Bicyclic peptide ligands specific for TGFbeta
GB201820307D0 (en) Bicyclic peptide ligands specific for cathepsin S
GB201818603D0 (en) Bicyclic peptide ligands specific for epha2
GB201820324D0 (en) Bicyclic peptide ligands specific for vegf
GB201820286D0 (en) Bicyclic peptide ligands specific for mt1-mmp
GB201720934D0 (en) Bicyclic peptide ligands specific for FAPalpha
GB201720933D0 (en) Bicyclic peptide ligands specific for cathepsin G
GB201712693D0 (en) Bicyclic peptide ligands specific for nectin-4
GB201720928D0 (en) Bicyclic peptide ligands specific for IL-6

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)